Arkolith/Insider Trading/APTO/Form 4

Seizinger Bernd R.

DirectorAptose Biosciences Inc. (APTO) · full profile →Form 4 · filed Sep 25, 2023
Net Buying
Open-Market Buys
$53K
Open-Market Sells
$0
Net Open-Market Flow
$53K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 22, 2023Buy(P)17K$3.14$53K17K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000912282-23-000385) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML